Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;16(3):381-394.
doi: 10.2174/0125899775295960240406073630.

Peptide Drugs: Current Status and it's Applications in the Treatment of Various Diseases

Affiliations
Review

Peptide Drugs: Current Status and it's Applications in the Treatment of Various Diseases

Chandni Chandarana et al. Curr Drug Res Rev. 2024.

Abstract

Peptides represent a class of natural molecules with diverse physiological functions, including hormone regulation, neurotransmission, and immune modulation. In recent years, peptide- based therapeutics have gained significant attention in pharmaceutical research and development due to their high specificity, efficacy, and relatively low toxicity. This review provides an overview of the current landscape of peptide drug development, highlighting the challenges faced in their formulation and delivery and the innovative strategies employed to overcome these hurdles. The review explores the wide range of applications of peptide drugs in treating various diseases, including HIV, multiple sclerosis, osteoporosis, chronic pain, diabetes, and cancer. Examples of FDA-approved peptide drugs and ongoing clinical trials are presented, showcasing the continuous advancements in peptide-based therapeutics across different therapeutic areas. This review underscores the promising potential of peptide drugs as targeted and effective treatments for a multitude of medical conditions, offering improved therapeutic outcomes and enhanced patient care.

Keywords: HIV; Peptide drugs; cancer; diabetes.; metabolic disorders; osteoporosis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Hemanth Kumar N.K.; Poornachandra Rao K.; Somashekaraiah R.; Jagannath S.; Sreenivasa M.Y.; Recent advances and challenges in peptide drug development. Antimicrobial Peptides 2023,1,297-310 - DOI
    1. Ganesh A.N.; Heusser C.; Garad S.; Sánchez-Félix M.V.; Patient-centric design for peptide delivery: Trends in routes of administration and advancement in drug delivery technologies. Med Drug Discov 2021,9,100079 - DOI
    1. Lau J.L.; Dunn M.K.; Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorg Med Chem 2018,26(10),2700-2707 - DOI - PubMed
    1. Fosgerau K.; Hoffmann T.; Peptide therapeutics: Current status and future directions. Drug Discov Today 2015,20(1),122-128 - DOI - PubMed
    1. Cao S.; Lv Z.; Guo S.; Jiang G.; Liu H.; An update - Prolonging the action of protein and peptide drugs. J Drug Deliv Sci Technol 2021,61,102124 - DOI

LinkOut - more resources